In vitro activity and in vivo efficacy of antimicrobial-coated vascular grafts

Annals of Vascular Surgery

Volumn 18, Issue 4, 2004, Pages 497-501

  Darouiche, Rabih O ^a,b   Mansouri, Mohammad D ^a,b  

^a Baylor College of Medicine ^*

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; MINOCYCLINE; POLITEF; RIFAMPICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; BLOOD VESSEL GRAFT; CONTROLLED STUDY; DEVICE INFECTION; DRUG EFFICACY; ENTEROCOCCUS FAECIUM; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; MATERIAL COATING; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RABBIT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 3543043740     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10016-004-0062-1     Document Type: Article

References (37)

1. Darouiche RO. Device-associated infections: a macroproblem that starts with microadherence. Clin. Infect. Dis. 2001;33:1567-1572.
2. Lin PH, Brinkman WT, Terramani TT, et al. Management of infected hemodialysis access grafts using cryopreserved human vein allografts. Am. J. Surg. 2002;184:31-36.
3. Lentino JR, Baddour LM, Wray M, et al. Staphylococcus aureus and other bacteremias in hemodialysis patients: antibiotic therapy and surgical removal of access site. Infection 2000;28:355-360.
4. Gassel HJ, Klein I, Steger U, et al. Surgical management of prosthetic vascular graft infection: comparative retrospective analysis of 30 consecutive cases. V.A.S.A. 2002;31:48-55.
5. Coselli JS, Koksoy C, LeMaire SA. Management of thoracic aortic graft infections. Ann. Thorac. Surg. 1999;67:1990-1993.
6. Reilly L. Aortic graft infection: evolution in management. Cardiovasc. Surg. 2002;10:372-377.
7. Yeager RA, Taylor LM, Jr, Moneta GL, et al. Improved results with conventional management of infrarenal aortic infection. J. Vasc. Surg. 1999;30:76-83.
8. Darouiche RO. Antimicrobial approaches for preventing infections associated with surgical implants. Clin. Infect. Dis. 2003;36:1284-1289.
9. Raad I, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. Ann. Intern. Med. 1997;127:267-274.
10. Darouiche RO, Raad II, Heard SO, et al. A comparison of two antimicrobial-impregnated central venous catheters. N. Engl. J. Med. 1999;340:1-8.
11. Chatzinikolau I, Finkel K, Hanna H, et al. Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective, randomized study. Am. J. Med. 2003;115:352-357.
12. Zabramski JM, Whiting D, Darouiche RO, et al. Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J. Neurosurg. 2003;98:725-730.
13. Darouiche RO, Smith JA, Jr, Hanna H, et al. Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial. Urology 1999;54:976-981.
14. Raad I, Darouiche R, Hachem R, et al. The broad spectrum activity and efficacy of catheters coated with minocycline and rifampin. J. Infect. Dis. 1996;173:418-424.
15. Darouiche RO, Meade R, Mansouri M, et al. In vivo efficacy of antimicrobial-coated fabric from prosthetic heart valve sewing rings. J. Heart Valve Dis. 1998;7:639-646.
16. Raad I, Darouiche R, Hachem R, et al. Antibiotics and prevention of microbial colonization of catheters. Antimicrob. Agents Chemother. 1995;39:2397-2400.
17. Darouiche RO, Hampel OZ, Boone TB, et al. Antimicrobial activity and durability of a novel antimicrobial-impregnated bladder catheter. Int. J. Antimicrob. Agents 1997;8:243-247.
18. Darouiche RO, Safar H, Raad II. In vitro efficacy of antimicrobial-coated bladder catheters in inhibiting bacterial migration along catheter surface. J. Infect. Dis. 1997;176:1109-1112.
19. Li H, Fairfax MR, Dubocq F, et al. Antibacterial activity of antibiotic coated silicone grafts. J. Urol. 1998;160:1910-1913.
20. Darouiche RO, Mansouri DM, Raad II. Efficacy of antimicrobial -impregnated silicone sections from penile implants in preventing device colonization in an animal model. Urology 2002;59:303-307.
21. Darouiche RO, Netscher DT, Meade R, et al. Activity of antimicrobial-impregnated silicone tissue expanders. Ann. Plast. Surg. 2002;49:567-571.
22. Darouiche RO, Meade R, Mansouri MD, et al. In vivo efficacy of antimicrobe-impregnated saline-filled silicone implants. Plast. Reconstr. Surg. 2002;109:1352-1357.
23. Darouiche RO, Mansouri MD, Meade R. In-vitro and in-vivo activity of antimicrobial-coated prosthetic heart valve sewing cuffs. J. Heart Valve Dis. 2002;11:99-104.
24. Hermann M, Vaudaux PE, Pittet D, et al. Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J. Infect. Dis. 1988;158:693-701.
25. Vaudaux P, Pittet D, Haeberli A, et al. Host factors selectively increase staphylococcal adherence on inserted catheters: a role for fibronectin and fibrinogen or fibrin. J. Infect. Dis. 1989;160:865-875.
26. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999;284:1318-1322.
27. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 2002;15:167-193.
28. Goeau-Brissonniere O, Leport C, Bacourt F, et al. Prevention of vascular graft infection by rifampin bonding to a gelatin-sealed Dacron graft. Ann. Vasc. Surg. 1991;5:408-412.
29. Vicaretti M, Hawthorne WJ, Ao PY, et al. An increased concentration of rifampicin bonded to gelatin-sealed Dacron reduces the incidence of subsequent graft infections following a staphylococcal challenge. Cardiovasc. Surg. 1998;6:268-273.
30. Gahtan V, Esses GE, Bandyk DF, et al. Antistaphylococcal activity of rifampin-bonded gelatin-impregnated Dacron grafts. J. Surg. Res. 1995;58:105-110.
31. Coggia M, Goeau-Brissonniere O, Leflon V, et al. Experimental treatment of vascular graft infection due to Staphylococcus epidermidis by in situ replacement with a rifampin-bonded polyester graft. Ann. Vasc. Surg. 2001;.15:421-429.
32. Bandyk DF, Novotney ML, Johnson BL, et al. Use of rifampin-soaked gelatin-sealed polyester grafts for in situ treatment of primary aortic and vascular prosthetic infections. J. Surg. Res. 2001;95:44-49.
33. Hayes PD, Nasim A, London NJM, et al. In situ replacement of infected aortic grafts with rifampicin-bonded prostheses: the Leicester experience (1992-1998). J. Vasc. Surg. 1999;30:92-98.
34. Widmer AF, Frei R, Rajacic Z, et al. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J. Infect. Dis. 1990;162:96-102.
35. Garrison JR, Jr, Henke PK, Smith KR, et al. In vitro and in vivo effects of rifampin on Staphylococcus epidermidis graft infections. A.S.A.I.O. J. 1997;43:8-12.
36. Maki DG, Stolz SM, Wheeler S, et al. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann. Intern. Med. 1997;127:257-266.
37. Sherertz RJ, Heard SO, Raad I, et al. Gamma-radiation-sterilized, triple-lumen catheters coated with a low concentration of chlorhexidine were not efficacious at preventing catheter infections in intensive care unit patients. Antimicrob. Agents Chemother. 1996;40:1995-1997.